SAA1 and cancer: Some identified peaks corresponded to some newly discovered ovarian cancer biomarkers, such as peaks 11,684.09 and 11,528.53 that have been identified as serum amyloid A1 and were found to be up regulated in cancer patients in comparison to patients with benign masses.